Bon Secours bets $5.7B on surgery centers. Revisit your outpatient plan
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in Blog
A large nonprofit health system has agreed to take a national surgery-center operator private, a clear signal that outpatient surgery is now a core health-system strategy rather than a side business.
What happened
On Oct. 26, HealthSpan Partners, an affiliate of Cincinnati-based Bon Secours Mercy Health, agreed to acquire Surgery Partners in a deal valued at about $5.7 billion including debt. Public shareholders will receive $23.50 per share in cash, a 49% premium over the prior close. Bain Capital, which owns roughly 39% of the company, will roll its stake into the new entity and stay on as a significant partner.
Surgery Partners brings more than 200 ambulatory surgery centers, surgical hospitals and physician practices across 30 states, about 5,000 affiliated physicians, and nine more surgery centers under construction. Bon Secours Mercy Health operates more than 45 hospitals. The buyer plans to fund the purchase with cash and new debt, and the parties expect to close in the first quarter of 2027, pending shareholder and regulatory approval.
Why it matters beyond one system
This is not an isolated move. Ascension bought AmSurg for $3.9 billion earlier this year. Two large nonprofit systems have now committed close to $10 billion to national outpatient surgery platforms.
The economics explain the urgency. A Strata analysis of more than 2,000 hospitals found operating margins climbed to 0.7% by June after starting 2026 in negative territory, while lower-acuity cases kept moving out of inpatient settings. Vizient projects outpatient volume will grow about 20% over the next decade, compared with about 7% for inpatient discharges. Outpatient procedures can cost up to half as much as the same service delivered inpatient, which is why payers and employers keep steering cases there.
For a system that does not own that capacity, the shift means profitable orthopedic, spine, GI and gynecology cases leave the hospital while the sickest, costliest patients stay.
Questions for your leadership team
- Volume exposure: What share of your surgical margin comes from procedures that payers can move to an ASC within three years?
- Physician alignment: Which of your high-volume surgeons already hold ASC ownership, and with whom?
- Partnership options: Would a joint venture with a national operator, a physician group or a neighboring system get you there faster than building?
- Balance sheet: If a competitor takes a large outpatient position in your market, how much debt capacity do you have to respond?
The deal still needs approvals, and analysts expect only limited antitrust overlap in Ohio and Kentucky. Either way, the direction of capital is clear.
Executive takeaway: Boards should ask management for a written outpatient surgery strategy, covering own, partner or cede, before the next budget cycle, because the largest nonprofit systems are already buying the platforms.